Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure and Function of Leukocytes

Structure and Function of Leukocytes

An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026

Same author

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

American journal of hematology·2026

Same author

Quantification of Vascular Burden on Cranial Vessel Wall Magnetic Resonance Imaging and Ophthalmic Complications in Giant Cell Arteritis.

ACR open rheumatology·2026

Same author

A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.

Seminars in arthritis and rheumatism·2026

Same author

Do Not Anchor on Vasculitis: Pancreatic Cancer Presenting With Isolated Celiac/Superior Mesenteric Artery Thickening.

ACR open rheumatology·2026

Same author

Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project.

Annals of the rheumatic diseases·2026

Same journal

A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus.

Annals of the rheumatic diseases·2026

Same journal

PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.

Annals of the rheumatic diseases·2026

Same journal

Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma.

Annals of the rheumatic diseases·2026

Same journal

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Annals of the rheumatic diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Plasma proteome profiling in giant cell arteritis.

Kevin Y Cunningham¹, Benjamin Hur², Vinod K Gupta²

¹Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, USA.

Annals of the Rheumatic Diseases

|August 17, 2024

Summary

This summary is machine-generated.

Plasma proteomic signatures can distinguish giant cell arteritis (GCA) from controls. Machine learning integration shows promise for discovering multiplex biomarkers for GCA diagnosis and management.

Keywords:

Giant Cell Arteritis Machine Learning Vasculitis

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

Related Experiment Videos

Last Updated: Jun 14, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

Area of Science:

Immunology
Proteomics
Vascular Inflammation

Background:

Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
Accurate diagnosis and monitoring of disease activity are crucial for effective GCA management.
Identifying reliable biomarkers for GCA remains an unmet clinical need.

Purpose of the Study:

To identify plasma proteomic signatures differentiating active and inactive GCA from non-disease controls.
To discover proteins associated with disease activity in GCA.
To evaluate the potential of plasma proteome profiling for GCA biomarker discovery.

Main Methods:

Prospective longitudinal study of 30 GCA patients (active and inactive disease) and 30 controls.
High-throughput aptamer-based proteomics assay analyzing over 7000 protein features.
Machine learning models (Random Forest) applied to plasma proteome data.

Main Results:

537 and 781 differentially abundant proteins identified between active GCA/controls and inactive GCA/controls, respectively.
16 proteins associated with active GCA disease.
Machine learning models accurately differentiated GCA patients from controls (95.0-98.3% accuracy).
Plasma proteins alone had limited ability to distinguish active from inactive GCA within patients.

Conclusions:

Plasma proteomic signatures offer potential for GCA diagnosis.
Integration of machine learning with proteomic data shows promise for multiplex biomarker discovery in GCA.
Further research is needed to refine biomarkers for distinguishing disease states.